España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
InspireMD
NSPR
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$3.19
0.09
2.90%
At close: -
$3.17
-0.02
-0.63%
After Hours: 4:29 PM EDT
Get Report
Comment
InspireMD (NSPR) Forecast
News
Earnings
InspireMD (NSPR) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for InspireMD (NASDAQ:NSPR) Stock
InspireMD Stock (NASDAQ: NSPR)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, February 13, 2025
InspireMD shares are trading higher after the...
Benzinga Newsdesk
InspireMD And Namsa Medtech Contract Research...
Benzinga Newsdesk
Thursday, December 12, 2024
InspireMD Says CFO Craig Shore Has Decided To...
Benzinga Newsdesk
Wednesday, December 11, 2024
Lake Street Initiates Coverage On InspireMD w...
Benzinga Newsdesk
Monday, December 09, 2024
InspireMD Enrolls First Patient in Clinical T...
Benzinga Newsdesk
Wednesday, December 04, 2024
CORRECTION: InspireMD Q1Numbers Are Old And W...
Benzinga Newsdesk
Tuesday, December 03, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Wednesday, November 13, 2024
InspireMD shares are trading higher after the...
Benzinga Newsdesk
Tuesday, November 12, 2024
InspireMD Q3 2024 GAAP EPS $(0.16) Beats $(0....
Benzinga Newsdesk
Earnings Scheduled For November 12, 2024
Benzinga Insights
Tuesday, October 15, 2024
InspireMD Reports Establishment Of Its Global...
Benzinga Newsdesk
Monday, October 07, 2024
InspireMD Says FDA Approved Investigational D...
Benzinga Newsdesk
Tuesday, September 17, 2024
Piper Sandler Reiterates Overweight on Inspir...
Benzinga Newsdesk
Monday, September 16, 2024
InspireMD Has Submitted A Premarket Approval ...
Benzinga Newsdesk
Tuesday, August 06, 2024
InspireMD Q2 2024 GAAP EPS $(0.22) Misses $(0...
Benzinga Newsdesk
Tuesday, May 28, 2024
InspireMD Presents One-Year Follow-Up Results...
Benzinga Newsdesk
Tuesday, May 14, 2024
InspireMD Q1 2024 GAAP EPS $(0.21) Misses $(0...
Benzinga Newsdesk
Tuesday, March 26, 2024
InspireMD Announces Abstract Of One-year Foll...
Benzinga Newsdesk
Wednesday, March 06, 2024
InspireMD Q4 EPS $(0.16) Beats $(0.20) Estima...
Benzinga Newsdesk
Earnings Scheduled For March 6, 2024
Benzinga Insights
Tuesday, March 05, 2024
Preview: InspireMD's Earnings
Benzinga Insights
Monday, February 12, 2024
InspireMD Appoints Principal Investigators Fo...
Benzinga Newsdesk
Wednesday, January 31, 2024
InspireMD Receives CE Mark Recertification Un...
Benzinga Newsdesk
Wednesday, December 20, 2023
InspireMD Reveals Issuance Of Key U.S. Patent...
Benzinga Newsdesk
Monday, November 27, 2023
InspireMD Enters Into An Agreement With Jacob...
Benzinga Newsdesk
Monday, November 06, 2023
Earnings Scheduled For November 6, 2023
Benzinga Insights
InspireMD Sold 2,734 CGuard EPS Stent Systems...
Benzinga Newsdesk
InspireMD Q3 EPS $(0.15), Inline, Sales $1.56...
Benzinga Newsdesk
Friday, November 03, 2023
InspireMD Earnings Preview
Benzinga Insights
Thursday, November 02, 2023
Piper Sandler Maintains Overweight on Inspire...
Benzinga Newsdesk
Wednesday, November 01, 2023
InspireMD Presents 30-Day Follow-Up Results F...
Benzinga Newsdesk
Thursday, October 12, 2023
InspireMD Announced Its Support For Centers F...
Benzinga Newsdesk
Thursday, August 31, 2023
InspireMD Announces Abstract Of 30-Day Results From The C-Guardians U.S. Investigational Device Exemption Clinical Trial Accepted for Presentation at VIVA23
Happy Mohamed
Wednesday, August 23, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Tuesday, August 08, 2023
InspireMD Q2 EPS $(0.24) Beats $(0.30) Estima...
Benzinga Newsdesk
Earnings Scheduled For August 8, 2023
Benzinga Insights
Friday, July 21, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Wednesday, July 12, 2023
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
Friday, June 30, 2023
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Monday, June 26, 2023
InspireMD Announces Completion Of Enrollment In C-Guardians U.S. Investigational Device Exemption Clinical Trial
Happy Mohamed
Monday, June 12, 2023
Benzinga's Top Ratings Upgrades, Downgrades For June 12, 2023
Benzinga Insights
Piper Sandler Initiates Coverage On InspireMD...
Benzinga Newsdesk
Tuesday, May 23, 2023
Inspiremd Inc Files For Stock Offering Of Up ...
Benzinga Newsdesk
Wednesday, May 17, 2023
National Alliance Securities Maintains Buy on...
Benzinga Newsdesk
Tuesday, May 16, 2023
InspireMD Earlier Reported Q1 EPS $(0.53) Beats $(0.68) Estimate, Sales $1.24M Beat $1.00M Estimate
Happy Mohamed
Monday, May 15, 2023
Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Why Are InspireMD Shares Surging Today
Nabaparna Bhattacharya
InspireMD shares are trading higher after the...
Benzinga Newsdesk
InspireMD Announces Private Placement Of Up T...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
